🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation

Recruitingn/aAges 18 Years - anyAllIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT03883711 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

AMIPE is both a retrospective and prospective study which was designed in order to collect data of patients with acute coronary syndromes and myocardial injury and to improve the knowledge about these conditions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient aged \> 18 years old * Acute coronary syndrome or myocardial injury * Written informed consent Exclusion Criteria: * under age or not able to give informed consent
💊

What it tests

  • Database
📍

Where

3 sites
Policlinico Sant'Orsola-Malpighi, Cardiology Department
Bologna, Italy
Ospedale Maggiore Carlo Alberto Pizzardi
Bologna, Italy
Ospedale Morgagni - Pierantoni
Forlì, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy